141 related articles for article (PubMed ID: 28671964)
1. Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling.
Ghotbaddini M; Cisse K; Carey A; Powell JB
PLoS One; 2017; 12(7):e0179844. PubMed ID: 28671964
[TBL] [Abstract][Full Text] [Related]
2. Four and a half LIM domain 2 alters the impact of aryl hydrocarbon receptor on androgen receptor transcriptional activity.
Kollara A; Brown TJ
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):51-8. PubMed ID: 19815066
[TBL] [Abstract][Full Text] [Related]
3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
4. The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells.
Richmond O; Ghotbaddini M; Allen C; Walker A; Zahir S; Powell JB
PLoS One; 2014; 9(4):e95058. PubMed ID: 24755659
[TBL] [Abstract][Full Text] [Related]
5. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.
Kraus S; Gioeli D; Vomastek T; Gordon V; Weber MJ
Cancer Res; 2006 Nov; 66(22):11047-54. PubMed ID: 17108144
[TBL] [Abstract][Full Text] [Related]
6. Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells.
Ding Y; Wang X; Xu A; Xu X; Tian K; Young CY; Yuan H
J Cell Biochem; 2011 Mar; 112(3):818-28. PubMed ID: 21328455
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells.
Tran C; Richmond O; Aaron L; Powell JB
Biochem Pharmacol; 2013 Mar; 85(6):753-62. PubMed ID: 23266674
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.
Morrow D; Qin C; Smith R; Safe S
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):27-36. PubMed ID: 15026081
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
[TBL] [Abstract][Full Text] [Related]
11. Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation.
Xie G; Peng Z; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1006-15. PubMed ID: 22361730
[TBL] [Abstract][Full Text] [Related]
12. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
13. Constitutive Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Progression.
Ghotbaddini M; Moultrie V; Powell JB
J Cancer Treatment Diagn; 2018; 2(5):11-16. PubMed ID: 31328183
[TBL] [Abstract][Full Text] [Related]
14. Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/Src association.
Migliaccio A; Castoria G; Auricchio F
Methods Mol Biol; 2011; 776():361-70. PubMed ID: 21796537
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
[TBL] [Abstract][Full Text] [Related]
16. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
17. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Indoles Activating the Aryl Hydrocarbon Receptor on Androgen Receptor Activity in the 22Rv1 Prostate Cancer Cell Line.
Zgarbová E; Vrzal R
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613955
[TBL] [Abstract][Full Text] [Related]
19. Short androgen receptor poly-glutamine-promoted endometrial cancer is associated with benzo[a]pyrene-mediated aryl hydrocarbon receptor activation.
Chen L; Bao BY; Chang WC; Ho JY; Cheng BH; Wang CL; Tang Q; Cheng WC; Chang HW; Hung YC; Ma WL
J Cell Mol Med; 2018 Jan; 22(1):46-56. PubMed ID: 28782227
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor regulates SRC expression through microRNA-203.
Siu MK; Chen WY; Tsai HY; Yeh HL; Yin JJ; Liu SY; Liu YN
Oncotarget; 2016 May; 7(18):25726-41. PubMed ID: 27028864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
